These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6442698)

  • 1. Plasma growth hormone responses to repetitive administrations of growth hormone releasing factor in patients with pituitary dwarfism.
    Hizuka N; Takano K; Shizume K; Hirose N; Ling NC
    Endocrinol Jpn; 1984 Dec; 31(6):697-704. PubMed ID: 6442698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma growth hormone (GH) responses to single and repetitive subcutaneous administration of GH releasing factor (hpGRF-44) in normal and GH deficient children.
    Takano K; Hizuka N; Shizume K; Honda N; Ling NC
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):11-9. PubMed ID: 3918397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma growth hormone (GH) response to GH-releasing factor in normal children with short stature and patients with pituitary dwarfism.
    Takano K; Hizuka N; Shizume K; Asakawa K; Miyakawa M; Hirose N; Shibasaki T; Ling NC
    J Clin Endocrinol Metab; 1984 Feb; 58(2):236-41. PubMed ID: 6420432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency.
    Borges JL; Blizzard RM; Gelato MC; Furlanetto R; Rogol AD; Evans WS; Vance ML; Kaiser DL; MacLeod RM; Merriam GR; Loriaux DL; Spiess J; Rivier J; Vale W; Thorner MO
    Lancet; 1983 Jul; 2(8342):119-24. PubMed ID: 6134978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.
    Borges JL; Blizzard RM; Evans WS; Furlanetto R; Rogol AD; Kaiser DL; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1984 Jul; 59(1):1-6. PubMed ID: 6427267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic growth hormone (GH) deficiency, and GH deficiency secondary to hypothalamic germinoma: effect of single and repeated administration of human GH-releasing factor (hGRF) on plasma GH level and endogenous hGRF-like immunoreactivity level in cerebrospinal fluid.
    Chihara K; Kashio Y; Abe H; Minamitani N; Kaji H; Kita T; Fujita T
    J Clin Endocrinol Metab; 1985 Feb; 60(2):269-78. PubMed ID: 3917456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pancreatic growth hormone releasing factor (hpGRF): GRF- and GH-levels after bolus injection and infusion of hpGRF.
    von Werder K; Losa M; Stalla GK; Bock L; Müller OA
    Acta Neurochir (Wien); 1985; 75(1-4):81-7. PubMed ID: 2986424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma GH and somatomedin C responses to single and repeated administrations of human growth hormone releasing factor (hGRF).
    Takano K; Hizuka N; Shizume K; Hirose N; Ling NC
    Endocrinol Jpn; 1985 Feb; 32(1):73-80. PubMed ID: 3926476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation.
    Webb CB; Vance ML; Thorner MO; Perisutti G; Thominet J; Rivier J; Vale W; Frohman LA
    J Clin Invest; 1984 Jul; 74(1):96-103. PubMed ID: 6429198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma growth hormone secretion during constant growth hormone-releasing factor infusion.
    Takano K; Hizuka N; Shizume K; Hirose N; Ling N
    Endocrinol Jpn; 1984 Dec; 31(6):681-5. PubMed ID: 6442696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary growth hormone response in rats during a 24-hour infusion of growth hormone-releasing factor.
    Wehrenberg WB; Brazeau P; Ling N; Textor G; Guillemin R
    Endocrinology; 1984 May; 114(5):1613-6. PubMed ID: 6143658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma GH response to hpGRF-44 in normal children of short stature and patients with GH deficiency.
    Takano K; Hizuka N; Shizume K; Ling NC
    Endocrinol Jpn; 1984 Feb; 31(1):41-8. PubMed ID: 6428864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human pancreatic growth hormone-releasing factor stimulates release of growth hormone in conscious unrestrained male rabbits.
    Chihara K; Minamitani N; Kaji H; Kodama H; Kita T; Fujita T
    Endocrinology; 1983 Dec; 113(6):2081-5. PubMed ID: 6139274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of synthetic human pancreatic growth hormone-releasing factor (hpGRF-44) on serum growth hormone response in normal and obese subjects].
    Shimizu T; Inoue K
    Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):82-96. PubMed ID: 3084310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative stimulation of growth hormone secretion in anaesthetized chickens by human pancreatic growth hormone-releasing factor (hpGRF) and thyrotrophin-releasing hormone (TRH).
    Harvey S; Scanes CG
    Neuroendocrinology; 1984 Oct; 39(4):314-20. PubMed ID: 6436724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone secretion in anaesthetized fowl. 1. Refractoriness to repeated stimulation by human pancreatic growth hormone-releasing factor (hpGRF) or thyrotrophin releasing hormone (TRH).
    Harvey S; Scanes CG; Phillips JG
    Gen Comp Endocrinol; 1985 Jul; 59(1):1-9. PubMed ID: 3926599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man.
    Vance ML; Borges JL; Kaiser DL; Evans WS; Furlanetto R; Thominet JL; Frohman LA; Rogol AD; MacLeod RM; Bloom S
    J Clin Endocrinol Metab; 1984 May; 58(5):838-44. PubMed ID: 6423660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pancreatic growth hormone-releasing factor (hpGRF-44) in acromegaly before and after adenomectomy. Modifications induced by somatostatin (GHRIH) infusion.
    Arosio M; Ambrosi B; Guglielmino L; Faglia G
    J Endocrinol Invest; 1985 Oct; 8(5):449-53. PubMed ID: 2867112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH)-releasing factor (GRF) pretreatment enhances the GRF-induced GH secretion in rats with the pituitary autotransplanted to the kidney capsule.
    Jansson JO; Carlsson L; Isaksson OG
    Endocrinology; 1985 Jan; 116(1):95-8. PubMed ID: 3917256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone, thyrotropin and prolactin responses to simultaneous administration of human growth hormone-releasing factor and thyrotropin releasing hormone in the bovine.
    Hodate K; Johke T; Ohashi S
    Endocrinol Jpn; 1985 Jun; 32(3):375-83. PubMed ID: 3930226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.